Detailed Information

Cited 0 time in webofscience Cited 0 time in scopus
Metadata Downloads

Early versus delayed bronchial artery embolization for non-massive hemoptysis

Authors
Park, Sung-JoonLee, SangjoonLee, Hyoung NamCho, Youngjong
Issue Date
Jul-2022
Publisher
Springer Verlag
Keywords
Hemoptysis; Bronchial arteries; Therapeutic embolization; Retrospective studies; Survival rate
Citation
European Radiology
Indexed
SCIE
SCOPUS
Journal Title
European Radiology
URI
https://scholarworks.korea.ac.kr/kumedicine/handle/2021.sw.kumedicine/61251
DOI
10.1007/s00330-022-08993-z
ISSN
0938-7994
Abstract
Objectives The aims of this study were to compare clinical outcomes of early versus delayed bronchial artery embolization (BAE) for non-massive hemoptysis and to investigate predictors of recurrent hemoptysis. Methods From March 2018 to February 2021, 138 consecutive patients (age, 65.5 ± 12.4 years; male, 67.4%) with non-massive hemoptysis underwent BAE. The enrolled patients were divided into an early embolization (EE) group (within the first 24 h, n = 79) and a delayed embolization (DE) group (n = 59). Results The time to embolization ranged between 0 and 15 days and was shorter in the EE group (0.47 ± 0.5 days) than in the DE group (4.02 ± 2.8 days, p < 0.001). The in-hospital clinical outcomes were not different between the two groups, except for hospital stay and post-embolization hospital stay. The recurrence-free survival in the EE group was significantly better than that in the DE group (p = 0.018). The time to embolization (hazard ratio (HR), 1.21; 95% confidence interval (CI), 1.04–1.42; p = 0.015) and aspergilloma (HR, 6.89; 95% CI, 2.08–22.86; p = 0.002) were predictive factors for recurrent hemoptysis. Conclusions BAE is an effective and safe treatment modality for non-massive hemoptysis. An early interventional strategy should be considered in patients presenting with non-massive hemoptysis to reduce the length of hospital stay and early recurrence. A delayed time to embolization and the presence of aspergilloma were independent risk factors for recurrent hemoptysis. Key Points • Bronchial artery embolization afforded good clinical improvement for treating non-massive hemoptysis without significant complications. • An early interventional strategy should be considered in patients presenting with non-massive hemoptysis to reduce the length of hospital stay and early recurrence. • A delayed time to embolization and the presence of aspergilloma were independent risk factors for recurrent hemoptysis.
Files in This Item
There are no files associated with this item.
Appears in
Collections
2. Clinical Science > Department of Radiology > 1. Journal Articles

qrcode

Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.

Related Researcher

Researcher Park, Sung-Joon photo

Park, Sung-Joon
안산병원 (Department of Radiology, Ansan Hospital)
Read more

Altmetrics

Total Views & Downloads

BROWSE